北京大学学报(医学版) ›› 2019, Vol. 51 ›› Issue (1): 165-170. doi: 10.19723/j.issn.1671-167X.2019.01.028

• 论著 • 上一篇    下一篇

12例原发性甲状腺淋巴瘤的病例回顾分析

张杨1,张继新2,石健3,于楠1,袁振芳1,卢桂芝1,高莹1,(),高燕明1,郭晓蕙1   

  1. 1. 北京大学第一医院 内分泌科, 北京 100034
    2. 北京大学第一医院 病理科, 北京 100034
    3. 北京大学第一医院 超声科, 北京 100034
  • 收稿日期:2017-11-17 出版日期:2019-02-18 发布日期:2019-02-26
  • 通讯作者: 高莹 E-mail:bjgaoying@yahoo.com
  • 基金资助:
    首都卫生发展科研专项青年优才项目(2018-4-4077);中华国际医学交流基金会甲状腺青年医师基金(2017N14)

A retrospective analysis of 12 cases of primary thyroid lymphoma

Yang ZHANG1,Ji-xin ZHANG2,Jian SHI3,Nan YU1,Zhen-fang YUAN1,Gui-zhi LU1,Ying GAO1,(),Yan-ming GAO1,Xiao-hui GUO1   

  1. 1. Department of Endocrinology, Peking University First Hospital, Beijing 100034, China
    2. Department of Pathology,Peking University First Hospital, Beijing 100034, China
    3. Department of Ultrasound, Peking University First Hospital, Beijing 100034, China
  • Received:2017-11-17 Online:2019-02-18 Published:2019-02-26
  • Contact: Ying GAO E-mail:bjgaoying@yahoo.com
  • Supported by:
    Supported by Capital Foundation of Medical Developments(2018-4-4077);and Thyroid Research Program of Young and Middle-aged Physicians from China International Medical Foundation(2017N14)

摘要:

目的: 通过分析原发于甲状腺的淋巴瘤(primary thyroid lymphoma,PTL)的临床特点,总结该病的诊治经验。方法:回顾性分析1995年1月至2015年9月北京大学第一医院收治的12例PTL病例的临床特点、诊治经过及预后。结果:12例PTL患者中男4例、女8例,平均年龄63岁(42~81岁),起病至诊断时间平均5个月(0.5~24个月)。其中1例因咳嗽、憋气就诊,余11例均因颈部肿物进行性增大就诊。除1例无甲状腺功能检查结果外,其余11例首诊时有7例为甲状腺功能减退,4例甲状腺功能正常。初诊11例行颈部B超,双侧均有结节者9例,肿瘤平均直径3.87 cm。4例经甲状腺部分切除术术后病理确诊,8例经甲状腺肿物粗针穿刺确诊,病理报告结果均为非霍奇金淋巴瘤,包括9例弥漫性大B细胞淋巴瘤、2例黏膜相关淋巴组织淋巴瘤(mucosa-associated lymphoid tissue lymphoma,MALToma)、1例小B细胞淋巴瘤,5例病理证实合并桥本甲状腺炎。除1例MALToma因考虑肿瘤相对惰性,未行化疗,余11例均予化疗。中位生存时间24个月(1~117个月),死亡3例。健在的9例患者中,7例化疗后定期随访肿瘤无进展,1例MALToma甲状腺肿物切除术后未予化疗及放疗,仍带瘤生存,1例仍在化疗中(2周期)。结论:中老年(尤其女性)桥本甲状腺炎患者出现迅速增大的甲状腺肿物,B超提示甲状腺结节或实质内不均质低回声,伴颈部淋巴结肿大和气管压迫时需高度警惕PTL的可能,对可疑病例适时采用粗针穿刺活检可以避免不必要的手术创伤,化疗为主要治疗手段。

关键词: 淋巴瘤, 甲状腺肿瘤, 桥本甲状腺炎

Abstract:

Objective: To discuss the clinical characteristics and diagnostic and therapeutic considerations of primary thyroid lymphoma (PTL) by reviewing PTL cases. Methods: In the study, 12 cases of PTL diagnosed and treated in Peking University First Hospital between January 1995 and September 2015 were identified. The clinical characteristics, management experiences and prognosis of these cases were reviewed retrospectively. Results: A total of 12 PTL patients (four males and eight females) were collected, with an average age of 63 years (42 to 81 years) at the time of diagnosis. The average time to clarify diagnosis was 5 months (0.5 to 24 months). Eleven patients presented with a rapidly growing neck mass and visited surgical department, except one complained of coughing and suffocated. Seven patients were hypothyroid, and four were euthyroid at the time of diagnosis. In sonography of 11 cases, nine showed bilateral nodules, with an average diameter of 3.87 cm. Pathologic diagnosis of non-Hodgkin’s lymphoma was confirmed in all the 12 cases by means of partial thyroidectomy (four) or core needle biopsy (eight). The pathological subtypes were diffuse large B cell lymphoma in nine patients, mucosa-associated lymphoid tissue lymphoma (MALToma) in two, and small B cell lymphoma in the other one patient. Five patients were concomitant with Hashimoto’s thyroiditis. Eleven patients received chemotherapy. Only one patient did not have any further treatment after operation due to an inertia type of tumor. The median overall survival time was 24 months (1-117 months), three patients died. Among the patients who survived, seven completed chemotherapy without disease progression, one MALToma case did not receive chemotherapy after thyroidectomy but was still alive with PTL, and one patient just finished his second course of chemotherapy. Conclusion: The diagnosis of PTL should be considered when dealing with rapidly growing goiters in elder female Hashimoto’s thyroiditis patients whose B ultrasound indicates hypoechogenicity in thyroid nodules or parenchyma, especially with lymphadenopathy and tracheal compressions. Timely use of coreneedle biopsy on suspicious cases can avoid unnecessary surgical trauma, and chemotherapy is the main treatment.

Key words: Lymphoma, Thyroid neoplasm, Hashimoto’s thyroiditis;

中图分类号: 

  • R736.1

表1

12例甲状腺淋巴瘤患者的临床特点"

Case Age/
Gender
Clinical symptoms Thyroid function,
TSH/(mIU/L)
Thyroid
antibody
B ultrasound Diagnose
method
Pathology Pathological
confirmed HT
Phase Chemotherapy Follow up/
months
Thyroid Lymph nodes
1 58/F Neck mass Normal TgAb+ Unknown Unknown Surgery DLBCL + RCHOP 74
2 61/M Neck mass Hypo, 8.19 TgAb+,
TPOAb+
Nodular type,bilobal lesion, lesion with inconspicuous border - Surgery MALToma + ⅡE No 46
3 58/F Neck mass, night sweats and weight loss Normal TgAb+ Diffuse type, bilobal lesion, lesion with clear boundary - CNB Small B cell
lymphoma
+ RCHOP 41*
4 42/F Neck mass with pain, difficulty swallowing Hypo, 8.36 - Diffuse type, bilobal lesion, lesion with inconspicuous border + CNB DLBCL - G-CHOP 24
5 73/F Neck mass Hypo, 13.37 - Diffuse type,left lobe lesion, lesion with clear boundary + FNA/CNB MALToma Unable to judge ⅡE RCHOP 24
6 73/F Neck mass with breathing and swallowing difficulty, hoarseness and drinking water cough Hypo, 10.17 TgAb+,
TPOAb+
Diffuse type,bilobal lesion, lesion with clear boundary + CNB DLBCL Unable to judge ⅡE RCHOP 22
7 81/M Neck mass with eating choked and difficulty
breathing
Hypo, 38.5 Not checked Mixed type, left lobe lesion, lesion with clear boundary, tracheal compression + CNB DLBCL Unable to judge COP 1*
8 75/M Hoarse voice and coughing Hypo, 132.01 TPOAb+ Mixed type, bilobal lesion, lesion with clear boundary, tracheal compression + CNB DLBCL Unable to judge ⅡE RCHOP 1*
9 53/M Submandibullar mass with swallowing and breathing difficulty Normal Not checked Nodular type,left lobe lesion, lesion with inconspicuous border + FNA/CNB DLBCL Unable to judge ⅡE RCHOP 105
10 73/F Neck mass Unknown Not checked Nodular type,bilobal lesion, lesion with clear boundary + Surgery DLBCL Unable to judge ⅡE CHOP 117
11 53/F Neck mass Normal Not checked Nodular type, right lobe lesion, lesion with inconspicuous border - Surgery DLBCL + ⅡE RCHOP 87
12 58/M Neck mass Hypo, 6.16 Not checked Mixed type, bilobal lesion, lesion with clear boundary + CNB DLBCL + RCHOP 2
[1] Stein SA, Wartofsky L . Primary thyroid lymphoma: a clinical review[J]. J Clin Endocrinol Metab, 2013,98(8):3131-3138.
doi: 10.1210/jc.2013-1428 pmid: 23714679
[2] Sarinah B, Hisham AN . Primary lymphoma of the thyroid: diagnostic and therapeutic considerations[J]. Asian J Surg, 2010,33(1):20-24.
doi: 10.1016/S1015-9584(10)60004-8 pmid: 20497878
[3] Onal C, Li YX, Miller RC , et al. Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study[J]. Ann Oncol, 2011,22(1):156-164.
doi: 10.1093/annonc/mdq310 pmid: 20587509
[4] Mack LA, Pasieka JL . An evidence-based approach to the treatment of thyroid lymphoma[J]. World J Surg, 2007,31(5):978-986.
doi: 10.1007/s00268-005-0768-z
[5] Alzouebi M, Goepel JR, Horsman JM , et al. Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre[J]. Int J Oncol, 2012,40(6):2075-2080.
doi: 10.3892/ijo.2012.1387 pmid: 22367111
[6] Sakorafas GH, Kokkoris P, Farley DR . Primary thyroid lymphoma (correction of lympoma): diagnostic and therapeutic dilemmas[J]. Surg Oncol, 2010,19(4):e124-e129.
doi: 10.1016/j.suronc.2010.06.002
[7] 李昌幼, 罗佐杰 . 原发性甲状腺淋巴瘤的发病机制及诊治现状[J]. 实用医学杂志, 2013,2(3):341-342.
doi: 10.3969/j.issn.1006-5725.2013.03.001
[8] Holm LE, Blomgren H, Lowhagen T . Cancer risks in patients with chronic lymphocytic thyroiditis[J]. N Engl J Med, 1985,312(10):601-604.
doi: 10.1056/NEJM198503073121001
[9] Noureldine SI, Tufano RP . Association of Hashimoto’s thyroiditis and thyroid cancer[J]. Curr Opin Oncol, 2015,27(1):21-25.
doi: 10.1097/CCO.0000000000000150 pmid: 25390557
[10] 朱坚, 费健 . 原发性甲状腺淋巴瘤的诊断和治疗分析[J]. 外科理论与实践, 2013,18(2):156-158.
[11] 谢婧, 邓先兆, 樊友本 , 等. 原发性甲状腺淋巴瘤疗效分析[J]. 中国普外基础与临床杂志, 2014,21(9):1097-1101.
[12] Ota H, Ito Y, Matsuzuka F , et al. Usefulness of ultrasonography for diagnosis of malignant lymphoma of the thyroid[J]. Thyroid, 2006,16(10):983-987.
doi: 10.1089/thy.2006.16.983 pmid: 17042683
[13] 杨光旭, 彭格红 . 原发性甲状腺淋巴瘤超声表现与病理对比分析[J]. 现代医药卫生, 2017,33(4):566-567.
doi: 10.3969/j.issn.1009-5519.2017.04.034
[14] Yang L, Wang A, Zhang Y , et al. 12 cases of primary thyroid lymphoma in China[J]. J Endocrinol Invest, 2015,38(7):739-744.
doi: 10.1007/s40618-015-0250-6 pmid: 25736543
[15] 骆惊涛, 魏玺, 张仑 . 原发性甲状腺淋巴瘤的超声表现病理及其他影像学特征分析[J]. 中国肿瘤临床, 2014,41(2):123-126.
doi: 10.3969/j.issn.1000-8179.20131453
[16] 彭晓琼, 蒲大容, 涂波 , 等. 原发性甲状腺恶性淋巴瘤的声像图特征及误诊分析[J]. 重庆医学, 2015,44(16):2260-2262.
doi: 10.3969/j.issn.1671-8348.2015.16.037
[17] 杨盼, 孙映荷, 马步云 , 等. 原发性甲状腺非霍奇金淋巴瘤的超声征象分析[J]. 中国普外基础与临床杂志, 2014,21(9):1092-1096.
[18] 张雨涵, 龚洪翰, 张宁 , 等. 原发甲状腺淋巴瘤的CT诊断与鉴别诊断[J]. 实用放射学杂志, 2014,30(7):1238-1240.
[19] Basu S, Li G, Bural G , et al. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility[J]. Acta Radiol, 2009,50(2):201-204.
doi: 10.1080/02841850802620689 pmid: 19089692
[20] Derringer GA, Thompson LD, Frommelt RA , et al. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases[J]. Am J Surg Pathol, 2000,24(5):623-639.
doi: 10.1097/00000478-200005000-00001
[21] 张秉均, 薛勇敢, 刘洪军 , 等. 20例原发性甲状腺淋巴瘤的临床分析[J]. 解放军医学院学报, 2015,36(5):419-423.
doi: 10.3969/j.issn.2095-5227.2015.05.004
[22] 夏青萍, 卫骆云 . 原发性甲状腺恶性淋巴瘤合并桥本氏甲状腺炎11例诊治分析[J]. 浙江实用医学, 2015,20(5):335-337.
[23] Sangalli G, Serio G, Zampatti C , et al. Fine needle aspirationcytology of primary lymphoma of the thyroid: a report of 17 cases[J]. Cytopathology, 2001,12(4):257-263.
doi: 10.1046/j.1365-2303.2001.00338.x pmid: 11488875
[24] 朱庆莉, 姜玉新, 李文波 , 等. 超声引导组织活检对原发性甲状腺淋巴瘤的诊断价值[J]. 协和医学杂志, 2014,5(1):3-7.
doi: 10.3969/j.issn.1674-9081.2014.01.002
[25] Matsuzuka F, Miyauchi A, Katayama S , et al. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based onour experience of 119 cases[J]. Thyroid, 1993,3(2):93-99.
doi: 10.1089/thy.1993.3.93
[26] Wang SA, Rahemtullah A, Faquin WC , et al. Hodgkin’s lymphoma of the thyroid: a clinicopathologic study of five cases andreview of the literature[J]. Mod Pathol, 2005,18(12):1577-1584.
doi: 10.1038/modpathol.3800501 pmid: 16258502
[27] Pyke CM, Grant CS, Habermann TM , et al. Non-Hodgkin’s lymphoma of the thyroid: is more than biopsynecessary?[J]. World J Surg, 1992,16(4):604-609.
doi: 10.1007/BF02067333 pmid: 1413831
[28] Molina A . A decade of rituximab: improving survival outcomes in non-Hodgkin’s lymphoma[J]. Annu Rev Med, 2008,59:237-250.
doi: 10.1146/annurev.med.59.060906.220345 pmid: 18186705
[29] Penney SE, Homer JJ . Thyroid lymphoma: acute presentation and long-termoutcome[J]. J Laryngol Otol, 2011,125(12):1256-1262.
doi: 10.1017/S0022215111001812 pmid: 21835073
[30] Belal AA, Allam A, Kandil A , et al. Primary thyroid lymphoma: a retrospective analysis of prognostic factors and treatment outcome for localized intermediate and high grade lymphoma[J]. Am J Clin Oncol, 2001,24(3):299-305.
doi: 10.1097/00000421-200106000-00019
[1] 廖栩鹤,王荣福,刘萌,陈雪祺,熊焰,农琳,殷雷,张炳晔,杜毓菁. 18F-FDG PET/CT半定量参数、表皮生长因子受体和间变淋巴瘤激酶基因突变对肺腺癌患者预后评估的价值[J]. 北京大学学报(医学版), 2021, 53(2): 246-254.
[2] 池彦廷,张延平,张秋露,刘翠苓,李斌斌. 唾液腺干燥综合征继发黏膜相关淋巴组织淋巴瘤的临床病理分析[J]. 北京大学学报(医学版), 2021, 53(1): 40-45.
[3] 程功,张霞,杨菲,程嘉渝,刘燕鹰. 以发热、关节炎、皮肤色素沉着为主要表现的血管免疫母细胞性T细胞淋巴瘤1例[J]. 北京大学学报(医学版), 2020, 52(6): 1150-1152.
[4] 田艳,朱军. p53 rs1625895基因多态性与弥漫大B细胞淋巴瘤预后相关性分析[J]. 北京大学学报(医学版), 2019, 51(5): 791-796.
[5] 宿骞,彭歆,周传香,俞光岩. 原发性腮腺淋巴瘤的临床病理特点及预后分析[J]. 北京大学学报(医学版), 2019, 51(1): 35-42.
[6] 刘爱春,陈勇,贾晋松,高松源,刘燕鹰. 酷似Mikulicz病的非霍奇金淋巴瘤1例[J]. 北京大学学报(医学版), 2016, 48(6): 1074-1076.
[7] 万文丽,王晶,朱明霞,张巍,克晓燕. CHOPE方案结合左旋门冬酰胺酶治疗T细胞淋巴瘤的回顾性分析[J]. 北京大学学报(医学版), 2016, 48(5): 841-845.
[8] 张梦雪1, 裴斐1△, 王田力2, 韩翔3, 由江峰1, 邹鹏程1, 王月琪1, 李绪文1, 刘鑫1, 钟镐镐1, 刘岩1, 王玉湘1, 王华1, 张波1. 95例非小细胞肺癌患者的间变性淋巴瘤激酶融合基因表达情况、临床病理特点及预后[J]. 北京大学学报(医学版), 2014, 46(4): 582-588.
[9] 傅志英, 朱军, 宋玉琴, 刘卫平, 季新强, 詹思延. 525例弥漫大B细胞淋巴瘤预后影响因素分析[J]. 北京大学学报(医学版), 2014, 46(3): 405-411.
[10] 陈建, 李桂莲, 柳平, 阙呈立, 王广发. 淋巴瘤样肉芽肿病1例及文献复习[J]. 北京大学学报(医学版), 2009, 41(4): 484-486.
[11] 彭年春, 郭晓蕙, 袁振芳, 高燕明. 甲状腺过氧化物酶免疫组织化学染色在甲状腺癌诊断中的应用[J]. 北京大学学报(医学版), 2008, 40(5): 548-550.
[12] 李挺, 祖幼立. 抗原受体基因重排克隆性分析淋巴瘤辅助诊断技术的发展和应用现状[J]. 北京大学学报(医学版), 2008, 40(4): 343-346.
[13] 任雅丽, 洪蕾, 农琳, 张爽, 李挺. 15例血管免疫母细胞T细胞淋巴瘤的临床病理、免疫组织化学及分子分析[J]. 北京大学学报(医学版), 2008, 40(4): 352-357.
[14] 时云飞, 刘翠苓, 周春菊, 宫丽平, 董丽娜, 李敏, 黄欣, 高子芬. 原发系统型间变性大细胞淋巴瘤间变性淋巴瘤激酶基因异常与其融合蛋白表达及预后分析[J]. 北京大学学报(医学版), 2008, 40(4): 380-386.
[15] 张爽, 农琳, 任雅丽, 李挺. 肝脾T细胞淋巴瘤临床病理学分析[J]. 北京大学学报(医学版), 2008, 40(4): 387-391.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 赵磊, 王天龙 . 右心室舒张末期容量监测用于肝移植术中容量管理的临床研究[J]. 北京大学学报(医学版), 2009, 41(2): 188 -191 .
[2] 万有, , 韩济生, John E. Pintar. 孤啡肽基因敲除小鼠电针镇痛作用增强[J]. 北京大学学报(医学版), 2009, 41(3): 376 -379 .
[3] 张燕, 韩志慧, 钟延丰, 王盛兰, 李玲玲, 郑丹枫. 骨骼肌活组织检查病理诊断技术的改进及应用[J]. 北京大学学报(医学版), 2009, 41(4): 459 -462 .
[4] 赵奇, 薛世华, 刘志勇, 吴凌云. 同向施压测定自酸蚀与全酸蚀粘接系统粘接强度[J]. 北京大学学报(医学版), 2010, 42(1): 82 -84 .
[5] 林红, 王玉凤, 吴野平. 学校生活技能教育对小学三年级学生行为问题影响的对照研究[J]. 北京大学学报(医学版), 2007, 39(3): 319 -322 .
[6] 丰雷, 程嘉, 王玉凤. 注意缺陷多动障碍儿童的运动协调功能[J]. 北京大学学报(医学版), 2007, 39(3): 333 -336 .
[7] 李岳玲, 钱秋瑾, 王玉凤. 儿童注意缺陷多动障碍成人期预后及其预测因素[J]. 北京大学学报(医学版), 2007, 39(3): 337 -340 .
[8] . 书讯[J]. 北京大学学报(医学版), 2007, 39(3): 225 -328 .
[9] 牟向东, 王广发, 刁小莉, 阙呈立. 肺黏膜相关淋巴组织型边缘区B细胞淋巴瘤一例[J]. 北京大学学报(医学版), 2007, 39(4): 346 -350 .
[10] 韩金涛, 赵军, 栾景源, 张龙. 多发结核性腹主动脉瘤一例[J]. 北京大学学报(医学版), 2007, 39(4): 361 -364 .